Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Ana M, Bajo"'
Publikováno v:
The Prostate. 82(8)
Growth hormone-releasing hormone (GHRH) and its receptors have been implicated in the progression of various tumors. In this study, we analyzed the carcinogenetic potential of exposure to GHRH of a nontumor human prostate epithelial cell line (RWPE-1
Autor:
Tomás Cuenca, Elena de la Torre-Rubio, Lourdes Gude, Laura Muñoz-Moreno, Eva Royo, Isabel de la Cueva-Alique, Ana M. Bajo
Publikováno v:
Dalton Transactions. 48:14279-14293
New water soluble, enantiopure palladium and platinum compounds RN-[M{(1S,4R)-κNOH,κ2NH(2-pic)}Cl]Cl and SN-[M{(1R,4S)-κNOH,κ2NH(2-pic)}Cl]Cl (2-pic = 2-picolyl, M = Pd 1 and 1', Pt 2 and 2', respectively), and heterometallic Pd/Ti [(η5-C5H5)2Ti
Autor:
Rafael Gómez, Alberto Fattori, Sandra García-Gallego, Maria Francesca Ottaviani, Paula Ortega, Riccardo Carloni, Michela Cangiotti, Natalia Sanz del Olmo, F. Javier de la Mata, Ana M. Bajo
Publikováno v:
Nanoscale. 11:13330-13342
Current cancer therapies present serious drawbacks including severe side-effects and development of drug resistance. Strategies based on nanosized metallodrugs combine the structural diversity and non-classical modes of action of metal complexes with
Autor:
Eva Vacas, María J. Carmena, Andrew V. Schally, Ana M. Bajo, Laura Muñoz-Moreno, Pedro L. Valenzuela, Juan C. Prieto
Publikováno v:
Peptides. 86:153-161
Triple-negative breast cancer (TNBC) is a subset of breast cancers which is negative for expression of estrogen and progesterone receptors and human epidermal growth factor receptor-2 (HER2). Chemotherapy is currently the only form of treatment for w
Autor:
Laura Muñoz-Moreno, Marta Maroto-Díaz, Sandra García-Gallego, Natalia Sanz del Olmo, F. Javier de la Mata, M. José Carmena, Rafael Gómez, Ana M. Bajo
Publikováno v:
e_Buah Biblioteca Digital Universidad de Alcalá
instname
instname
Background Prostate cancer is the fifth cause of death among men worldwide. Patients suffering resistant prostate tumor, unresponsive to common treatments, can only be treated with palliative therapy. Materials and methods Ruthenium(II) carbosilane m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cdc20968f39415bd299552d7b55311d
http://hdl.handle.net/10017/46748
http://hdl.handle.net/10017/46748
Autor:
Ana M. Bajo, Laura Muñoz-Moreno, María I. Arenas, Andrew V. Schally, Juan C. Prieto, Manuel Sánchez-Chapado, María J. Carmena
Publikováno v:
Oncotarget
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Growth hormone-releasing hormone (GHRH) and its receptors have been implicated in the progression of various tumors. In vitro and in vivo studies have demonstrated that GHRH antagonists inhibit the growth of several cancers. GHRH antagonists, JMR-132
Autor:
Natalia Sanz del Olmo, Sandra García-Gallego, F. Javier de la Mata, Paula Ortega, Rafael Gómez, Maria Bryszewska, Ana M. Bajo, Maksim Ionov
Publikováno v:
European Journal of Medicinal Chemistry. 199:112414
In searching for efficient and selective antitumour drugs, a new family of carbosilane metallodendrimers functionalized with [Ru(η5-C5H5)(PTA)Cl] (PTA = 1,3,5-triaza-7-phosphatricyclo-[3.3.1.1] decane) is reported. Experiments of the biophysical cha
Publikováno v:
The Prostate. 78(12)
BACKGROUND Therapeutic strategies should be designed to transform aggressive prostate cancer phenotypes to a chronic situation. To evaluate the effects of the new growth hormone-releasing hormone receptor (GHRH-R) antagonists: MIA-602, MIA-606, and M
Autor:
Laura Muñoz-Moreno, Isabel de la Cueva-Alique, Tomás Cuenca, Ana M. Bajo, Eva Royo, Adrián Pérez-Redondo, Isabel Marzo, Sara Sierra, Lourdes Gude
Publikováno v:
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
instname
New water soluble, enantiopure arene ruthenium compound S Ru S N -(1 R ,4 S )-[(η 6 - p -cymene)Ru{ĸNH(Bn),ĸNOH}Cl]Cl (Bn = benzyl, 1a ′) has been synthesized. The novel compound along with that previously described R Ru R N -(1 S ,4 R )-[(η 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c008e63bb5ceb36d80e370e7128a7ee1
http://zaguan.unizar.es/record/78316
http://zaguan.unizar.es/record/78316
Autor:
Laura Muñoz-Moreno, Eva Royo, Ana M. Bajo, María Contel, Yosra Benabdelouahab, Isabel de la Cueva-Alique, Tomás Cuenca, Malgorzata Frik, Mohammed Amin El Amrani
Publikováno v:
European Journal of Inorganic Chemistry. 2015:2295-2307
The investigation of the hydrogen-bonding effect on the aggregation tendency of ruthenium compounds [(η6-p-cymene)Ru(κNHR,κNOH)Cl]Cl (R = Ph (1a), Bn (1b)) and [(η6-p-cymene)Ru(κ2NH(2-pic),κNOH)][PF6]2 (1c), [(η6-p-cymene)Ru(κNHBn,κNO)Cl] (2